Wambolt & Associates’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.27M | Sell |
32,532
-2,163
| -6% | -$151K | 0.76% | 41 |
|
|
2025
Q1 | $2.36M | Buy |
34,695
+2,280
| +7% | +$155K | 0.8% | 42 |
|
|
2024
Q4 | $2.79M | Sell |
32,415
-3,301
| -9% | -$284K | 0.89% | 32 |
|
|
2024
Q3 | $4.21M | Buy |
35,716
+2,957
| +9% | +$349K | 1.15% | 25 |
|
|
2024
Q2 | $4.76M | Buy |
32,759
+2,489
| +8% | +$362K | 1.38% | 15 |
|
|
2024
Q1 | $3.86M | Buy |
30,270
+4,554
| +18% | +$581K | 1.15% | 21 |
|
|
2023
Q4 | $2.66M | Buy |
25,716
+6,005
| +30% | +$621K | 0.87% | 29 |
|
|
2023
Q3 | $1.81M | Buy |
19,711
+4,079
| +26% | +$374K | 0.66% | 41 |
|
|
2023
Q2 | $1.26M | Buy |
15,632
+1,356
| +9% | +$110K | 0.45% | 83 |
|
|
2023
Q1 | $1.14M | Buy |
+14,276
| New | +$1.14M | 0.4% | 92 |
|
|
2019
Q1 | – | Sell |
-12,954
| Closed | -$298K | – | 156 |
|
|
2018
Q4 | $298K | Buy |
+12,954
| New | +$298K | 0.33% | 104 |
|